391 related articles for article (PubMed ID: 21048784)
1. Does tumour dormancy offer a therapeutic target?
Goss PE; Chambers AF
Nat Rev Cancer; 2010 Dec; 10(12):871-7. PubMed ID: 21048784
[TBL] [Abstract][Full Text] [Related]
2. Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer.
Gu Y; Bui T; Muller WJ
Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35560214
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells in early-stage breast cancer.
Sinha G
J Natl Cancer Inst; 2012 Nov; 104(22):1693-4. PubMed ID: 23111190
[No Abstract] [Full Text] [Related]
4. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
[TBL] [Abstract][Full Text] [Related]
5. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
[TBL] [Abstract][Full Text] [Related]
6. Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours.
Selli C; Turnbull AK; Pearce DA; Li A; Fernando A; Wills J; Renshaw L; Thomas JS; Dixon JM; Sims AH
Breast Cancer Res; 2019 Jan; 21(1):2. PubMed ID: 30616553
[TBL] [Abstract][Full Text] [Related]
7. Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse.
Lobodasch K; Fröhlich F; Rengsberger M; Schubert R; Dengler R; Pachmann U; Pachmann K
Breast; 2007 Apr; 16(2):211-8. PubMed ID: 17291754
[TBL] [Abstract][Full Text] [Related]
8. [Tumor dormancy and identification of therapeutic targets].
Li CF; Cao S; Meng SD
Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
[TBL] [Abstract][Full Text] [Related]
9. [Trastuzumab, a new treatment approach in breast carcinoma].
Raab G; Eiermann W
Internist (Berl); 2001 Jun; 42(6):835-40, 842. PubMed ID: 11449630
[No Abstract] [Full Text] [Related]
10. Targeting the HER2 receptor in metastatic breast cancer.
Orphanos G; Kountourakis P
Hematol Oncol Stem Cell Ther; 2012; 5(3):127-37. PubMed ID: 23095788
[TBL] [Abstract][Full Text] [Related]
11. The Significance of Circulating Tumour Cells in the Clinic.
Abalde-Cela S; Piairo P; Diéguez L
Acta Cytol; 2019; 63(6):466-478. PubMed ID: 30820013
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Tumor Cells and Dormancy in Breast Cancer Progression.
Banys-Paluchowski M; Reinhardt F; Fehm T
Adv Exp Med Biol; 2020; 1220():35-43. PubMed ID: 32304078
[TBL] [Abstract][Full Text] [Related]
13. What is the best choice of partner chemotherapy with trastuzumab for metastatic breast cancer?
Gourmelon C; Frenel JS; Campone M
Expert Rev Anticancer Ther; 2012 Feb; 12(2):195-201. PubMed ID: 22316367
[TBL] [Abstract][Full Text] [Related]
14. Role of Herceptin in primary breast cancer: views from North America and Europe.
Leyland-Jones B; Smith I
Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792
[TBL] [Abstract][Full Text] [Related]
15. Anti-HER2 therapy for metastatic breast cancer in low- and middle-income countries: bridging the gap between clinical trials and real life.
Soares LR; Rosa VDL; Freitas-Junior R
Breast Cancer Res Treat; 2020 Jun; 181(3):693-694. PubMed ID: 32350678
[No Abstract] [Full Text] [Related]
16. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
Quayle L; Ottewell PD; Holen I
Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
[TBL] [Abstract][Full Text] [Related]
17. New treatment paradigms for optimizing survival in advanced and metastatic breast cancer.
Perez EA; Burris HA; Mooberry S; Tripathy D
Clin Adv Hematol Oncol; 2012 Aug; 10(8 Suppl 13):1-14; quiz 15-6. PubMed ID: 23072876
[No Abstract] [Full Text] [Related]
18. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.
Allan AL; Vantyghem SA; Tuck AB; Chambers AF
Breast Dis; 2006-2007; 26():87-98. PubMed ID: 17473368
[TBL] [Abstract][Full Text] [Related]
19. Tumour dormancy in breast cancer: an update.
Brackstone M; Townson JL; Chambers AF
Breast Cancer Res; 2007; 9(3):208. PubMed ID: 17561992
[TBL] [Abstract][Full Text] [Related]
20. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
